September 2023, Vol 4, No. 9

This JAMA Forum discusses ways the opioid settlement funds could be used to save lives today and in the future, aspects of the decisions surrounding funding, and the importance of measuring progress.

This Viewpoint discusses gaps in collection systems for health care data in US territories.

This cross-sectional study examines the association of impairment and disability identity with perceptions of procedural justice among adults with disabilities living in the US.

This cohort study investigates the association of New York state’s Medicaid value-based payment reform with utilization patterns in patients with mental illness.

This JAMA Forum discusses categories of artificial intelligence devices such as clinical decision support tools and large language models that are increasing being used in health care and the improvements needed to ensure the accuracy and rigor of these tools for patient use.

This Viewpoint explores the challenges and opportunities for remote therapeutic monitoring as an innovative mental health treatment model.

This cross-sectional study assesses enrollment and disenrollment patterns for Medicare Advantage plans from 2013 to 2018 among beneficiaries with complex health conditions, including Alzheimer disease and related dementias.

This cohort study examines opportunities for accountable care organizations and other risk-bearing organizations to achieve savings by steering patients to efficient medical oncology practices operating in specific geographic areas.

This JAMA Forum discusses climate change efforts to promote hope among adolescents.

This Viewpoint describes new federal updates to screening mammography rules and recommends strategies for mitigating potential consequences of the rules.

This cross-sectional study assesses the extent to which Medicare Part B spending growth was associated with changes in price vs quantity, and how these trends interact with entry of new drugs into the marketplace.

This cross-sectional study evaluates whether research and nonresearch payments from drug manufacturers play a role in opthalmologists’ selection of therapies for age-related macular degeneration.

This cross-sectional study analyzes Medicare Advantage surveys to compare Medicare and Medicaid dual-eligible individuals’ experiences with care across 3 established categories of plans.

This JAMA Forum discusses Title VII challenges to vaccination mandates, the Groff v DeJoy decision, and the implications of the decision for health care employers.

This Viewpoint compares the research and development costs for a drug’s first indication with supplemental indications to demonstrate that the cost of approval for supplemental indications may be substantially lower.

This quality improvement study examines the use of a weighted lottery system to allocate a limited number of doses of tixagevimab with cilgavimab equitably to disadvantaged populations.

This case-control study compares health care use, cost, and delivery for patients before vs after their primary care physician enters a vertical relationship, including ownership, affiliation, and joint contracting, with a health system.

This cohort study examines changes in volume of in-person vs virtual visits to independent and integrated practices during the COVID-19 pandemic.